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Abstract: Effects of vagus nerve stimulation in visceral pain model.
Visceral pain is an important therapeutic problem. A number of studies have established that 
abdominal vagal afferents modulate somatic pain behavior. Although it is not clear if vagal 
afferents transmit nociceptive information, a change in their activity can increase or decrease 
nociceptive transmission in visceral pain. Aims of the present study were to determine whether 
the subdiaphragmatic vagus nerves play a role in the endogenous pain inhibitory mechanisms 
in visceral pain model and whether it involves opioidergic pathways.
 Data obtained in our studies show that vagus nerve plays the direct role in conveying the 
nociceptive information in the peritonitis model of visceral pain. We have shown, that vagal 
afferents exhibit an increase in excitability and subdiaphragmatic vagotomy decrease nociceptive 
behavior in visceral pain in rats. We have also tested two different stimulation parameters of 
chronic subdiaphragmatic vagal nerve stimulation: VNS1 (high-intensity) and VNS2 (low-intensity) 
in visceral pain model in rats. Both stimulation parameters increased pain threshold but VNS1 
was more effective than VNS2. Naloxone inhibited the antinociceptive effects of VNS, reversing 
partially increase in the pain threshold in rats and increases number of writhes in visceral pain 
model. Therefore, our data indicate that this analgesic effect of the VNS is mediated, at least in 
part, by descending opioidergic pathways.
 The present study has confi rmed the importance of vagal afferents for nociception in general 
and proven that this role is not limited to somatic pain but also extends to visceral pain.
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The vagus nerve contains mostly afferent fi bers that innervate thoracic and 
abdominal viscera conveying information important for the feedback modulation 
of homeostatic and allostatic functions such as circulation, respiration, 
gastrointestinal, and neuroendocrine systems [1]. The activity in these afferents 
also modulate the infl ammatory process, including infl ammatory hyperalgesia 
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[2–4]. Our previous work has helped delineate details of how vagal afferent 
activity affects components of the infl ammatory response, and recently, we 
have detected several aspects of this modulation [5–7]. Several previous studies 
have also documented the role of vagally mediated afferent neural signals in 
modulation of pain perception [8–11]. Although it is not clear if vagal afferents 
transmit nociceptive information, a change in their activity can increase or 
decrease nociceptive transmission in visceral pain. The effects of vagotomy or 
simulation of the cut nerve were studied acutely on behavioral responses to 
painful stimuli and overall conclusion was that under certain conditions vagal 
afferent stimulation had an analgesic potential [12–14].
Vagotomy studies demonstrate that vagal afferent integrity is essential to 
the effi cacy of different analgesic treatments like morphine [13]. Furthermore, 
subdiaphragmatic vagotomy decreases the threshold for mechanically induced 
hind paw withdrawal in rats [8, 12], increases sensitivity to various noxious 
lesions [15] and enhances hyperalgesia induced by bradykinin [8, 16]. Vagotomy 
resulting in a chronic elevation in plasma concentration of epinephrine mediate 
the effects of the adrenal medulla on pain signaling [17]. However, vagotomy 
also prevents the establishment of kainic acid-induced hyperalgesia in mice [18] 
and reduces nociception in the formalin test in male rats [9].
Stimulation of vagal afferents (VNS) in rodents can raise or lower base-
line nociceptive thresholds and can either increase or decrease the magnitude 
of hyperalgesia [13]. The analgesic effect of VNS seems to depend on a criti-
cal stimulation intensity that activates C fi bers [19]. Vagus nerve stimulation 
(VNS) therapy for treatment of epilepsy enabled assessment of its effect on 
pain in human. Like in the animal study, the clinical data showed contradic-
tory results. In one study, VNS induced a signifi cant decrease of thermal pain 
threshold [20]. On the contrary, in another study, VNS produced an increase 
in mechanical pain threshold but no change of heat pain thresholds [21]. In 
addition, pain perception has also been assessed in healthy human volunteers 
after vagal afferent activation by a rapid fi lling of the stomach with water [22]. 
Heat pain threshold was increased after such gastric distension while mechani-
cal pain threshold was not signifi cantly altered. On the other hand, Holtmann 
et al. [23] reported lower thresholds for the percepcion of pain in patiens who 
had previously undergone vagotomy in course of a Billroth I gastrectomy, com-
pared to those in healthy controls. Moreover, Ajao et al. [24] reported that 
vagotomy defi nitely reduces the pain associated with terminal upper gastroin-
testinal neoplasms.
However, there is no report to investigate whether subdiaphragmatic vago-
tomy changes the pain threshold in infl ammatory visceral pain. Furthermore, 
the infl uences of chronic electrical stimulation of subdiaphragmatic vagal af-
ferent nerves on visceral pain evoked by infl ammatory stimuli have not been 
investigated. 
59
Persistent abdominal pain or discomfort represent the most frequently men-
tioned complaints of patients and is important therapeutic problem [25]. There-
fore, we decided to use in our study the “Writhing Test” (visceral pain model). 
Aims of the present study were to determine: whether the subdiaphragmatic 
vagus nerves play a role in the endogenous pain inhibitory mechanisms follow-
ing infl ammatory visceral pain and whether it involves opioidergic pathways.
MATERIALS AND METHODS
Male Wistar rats weighting 250–300 g were housed at a room temperature 
(22 ± 2 C°) and on a 12 hours light/day cycle. Standard laboratory food 
(Labofeed B, Poland) and tap water were provided ad libitum. Before every 
experiment rats were food deprived for 12 hours. Studies were approved by the 
Ethic Committee for Animal Research of Jagiellonian University (92/2010).
Expe r imenta l  v i s ce ra l  pa in  mode l  (WR )
Nociceptive activity was tested in rats using the writhing model [7]. We used 
acetic acid (10 ml/kg 0.6% solution), stimulus known to produce infl ammation 
as well as writhing response in rats. The rats had the nociceptive stimuli injected 
into the peritoneal cavity. Controls were injected with saline. The intensity of 
nociception was quantifi ed by counting the number of writhes occurring during 
30 min after acetic acid injection. The writhing response consists of a contraction 
of the abdominal muscles together with a stretching of hind limbs.
c -Fos  express i on  in  nodose  gang l i on  (NG )
After Vetbutal overdosing inferior vagal ganglions (NG, nodose ganglions) were 
bilaterally prepared and sampled to histochemical evaluations. The preparations 
were fi xed and then frozen. Frozen preparation was sliced by using cryostat 
and subsequently submitted to the immunohistochemical staining. The 
specimens were incubated with rabbit c-Fos antibody (K-25; Sc-253) (Santa 
Cruz Biotechnology). After 3 times repeated PBS washing the specimens were 
incubated with second degree biotinylated goat anti-rabbit antibody (Jackson 
ImmunoResearch, West Grave, PA). Afterwards the specimens were incubated 
with streptavidin — Cy3 complex (Jackson ImmunoResearch, West Grave, PA). 
Then the specimens were embedded in fluorescent specimen’s medium 
(DAKOCytomation, Denmark). Negative controls were conducted without 
the fi rst antibody. The specimens were analyzed under the Zeiss Axsioscop 
fl uorescent microscope.
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Neuroe l e c t r ophys i o l og i ca l  s tud i es
The activity of single vagal afferents was recorded as previously described [26]. 
Rats were anesthetized with pentobarbital sodium (40 mg/kg, i.p.) and placed 
in a supine position with the head gently clamped in place. Body temperature 
was monitored by a rectal thermal probe and was maintained at 36–37°C by 
a warm-water heating pad. Artifi cial ventilation was carried out throughout 
the experiments via a tracheal cannula. The left trunk of the vagus was gently 
separated from the carotid artery. To electrically isolate the nerve, a piece of 
Tefl on tape was placed under it and the site was fi lled with paraffi n oil (37°C). 
A small bundle of nerve fi bers was peeled off and cut free from the main trunk, 
and the cut end was placed on a bipolar platinum wire electrode (A-M Systems, 
Carlsborg, WA). A reference electrode was placed in the epineurium. Neural 
activity was sampled at 20 kHz and amplifi ed using standard techniques 
(PowerLab/8SP ADInstruments, Australia) and fi bers with obvious spontaneous 
activity were recorded for the 30 min periods on PC hard disc. Vagal afferents 
discharges were analysed with dual time-amplitude windows discriminator 
software (Spike Histogram v.2 ADInstruments). Then, the activities (spikes/s) 
of vagal afferent fi bers were analyzed with ANOVA followed by Tukey's tests. 
Results were expressed as means ± SEM and p < 0.05 considered signifi cant.
Vago tomy
Subdiaphragmatic vagotomy were performed on rats (n = 8) as previously 
described [27]. Briefl y, after an overnight fast, rats were anesthetized using 
pentobarbital (40 mg/kg ip). After a midline laparotomy, the stomach and 
lower esophagus were gently retracted from the abdominal cavity. For the 
total vagotomy, the two vagal trunks were exposed and cut. All neural and 
connective tissue surrounding the esophagus immediately below the diaphragm 
was removed to transect all small vagal branches. Sham animals were also 
prepared (n = 8). For the sham vagotomy, the viscera were similarly handled, 
but no nerves were cut. The incisions were closed in layers. Postoperatively, the 
animals were observed and weighed daily to monitor the general health of the 
animals. Rats that failed to gain body mass were euthanized with pentobarbital. 
Studies were done after 7 days after surgery.
Vagus nerve stimulation (VNS)
To asses VNS antinociceptive effect on visceral pain (WR), four experimental 
groups of eight animals were established:
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1. Animals with WR
2. Animals with WR receiving VNS (divided in two subgroups with different 
parameters: VNS1 and VNS2)
3. Animals with WR treated with naloxone (1 mg/kg sc)
4. Animals with WR receiving VNS treated with naloxone (1 mg/kg sc)
In groups 2 and 4 in visceral pain model left vagus nerve below diaphragm 
was dissected from esophagus and electrodes were wrapped around the nerve 
with the positive electrode placed distally. The stimulator device (Institute of 
Electron Technology, Cracow, Poland) was implanted in a subcutaneous pocket 
on the back of the rats [28]. At least fi ve days were allowed for recovery before 
starting experiments. After pilot study, following stimulation parameters were 
used: 
VNS1 — 2 mA, 20 Hz, 0.5 msec pulse with, 20 s on/18 off duty cycle
VNS2 — 40 μA, 20 Hz, 0.5 msec pulse with, 30 s on/30 s off duty cycle
RESULTS
Ef f e c t  o f  subd iaphragmat i c  vago tomy
To determine whether subdiaphragmatic vagus nerves are involved in the 
modulation of visceral pain chronic bilateral subdiaphragmatic vagotomy was 
performed. Data were collected from 8 sham-operated control rats and 8 rats 
after vagotomy. Chronic subdiaphragmatic vagotomy produced a marked 
decrease in number of abdominal muscle contractions compared to sham 
operation (p < 0,05). Our results provide evidence that subdiaphragmatic 
vagotomy decreases nociceptive behavior in visceral pain. 
E ffects of visceral pain on vagal afferents activity and c -Fos
expression in nodose ganglia
Visceral pain increased both vagal afferents discharges frequency and c-Fos 
expression in NG (p < 0.05). Our data indicate that vagal afferents are directly 
involved in visceral hyperalgesia. Intraperitoneal acetic acid injection induces 
chemical peritonitis and this infl ammatory process gives the way to hyperalgesia. 
We have shown, that in the presence of infl ammation, vagal afferents exhibit an 
increase in excitability. Naloxone — a nonselective opiod receptors antagonist 
did not affect vagal afferents activity.
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Fig 1. Effect of subdiaphragmatic vagotomy (vag) on the writhing response (WR) induced 
by acetic acid in conscious rats. The number of writhes was determined for the interval 
of 0–30 min, after i.p. injection of acetic acid (10 ml/kg 0.6% solution). 
Results are expressed as means ±SD for groups of eight rats;
* p < 0.05
Fig. 2. c-Fos expression in NG (nodose ganglion) in visceral pain (WR — writhing response); 
* p < 0.05
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Fig. 3. Frequency of vagal afferents discharge in visceral pain
(WR — writhing response; NX — naloxone); 
* p < 0.05
Fig. 4. Rate histogram of vagal afferents discharge in visceral pain model (WR).
Number of spikes is plotted against time. Naloxone did not affect spontaneous 
vagal afferents activity
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Effects of vagal nerve stimulation on visceral pain
We have tested two different stimulation parameters of chronic subdiaphragmatic 
vagal nerve stimulation: VNS1 (high-intensity) and VNS2 (low-intensity) 
in visceral pain model in rats. Both stimulation parameters increased pain 
threshold (p < 0.05). VNS1 was more effective than VNS2 in visceral pain. 
Naloxone — a nonselective opiod receptors antagonist — partially reversed 
Fig. 5. Infl uence of VNS1 [2 mA, 20 Hz, 0.5 msec pulse with, 20 s on/18 off duty cycle]
on visceral pain (WR — writhing response; VNS — vagal nerve stimulation; NX — naloxone)
* p < 0.05
Fig. 6. Infl uence of VNS2 [40 μA, 20 Hz, 0.5 msec pulse with, 30 s on/30 s off duty cycle]
on visceral pain (WR — writhing response; VNS — vagal nerve stimulation; NX — naloxone) 
* p < 0.05
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antinociceptive effects of VNS, causing the decrease in the pain threshold and 
the increase nociceptive behavior (p < 0.05).
DISCUSSION
The key findings of the our study are as follows: visceral pain increased 
excitability of vagal sensory fibres; subdiaphragmatic vagotomy decrease 
nociceptive behavior in visceral pain; chronic VNS may be effective to alleviate 
visceral pain and this analgesic effect is mediated in part, by opioidergic 
pathways.
Although it is commonly assumed that vagal afferents are not involved in 
nociception and pain, there is growing evidence that they play a complex role in 
these processes [1]. The change of the activity in the vagus nerve, especially the 
subdiaphragmatic vagus nerve, affects nociceptive responses [8, 13, 29]. The 
present study has confi rmed the importance of vagal afferents for nociception 
in general and proven that this role is not limited to somatic pain but also 
extends to visceral pain. We have shown that subdiaphragmatic vagotomy 
decrease nociceptive behavior in visceral pain. We have also shown, that in 
the presence of infl ammation, vagal afferents exhibit an increase in excitability 
(visceral pain increased both vagal afferents discharges frequency and c-Fos 
expression in NG). 
Vagotomy also prevents the establishment of kainic acid-induced hyperal-
gesia [18] and reduces nociception in the formalin test in rats [9]. On the other 
hand several studies demonstrate that subdiaphragmatic vagotomy decreases 
the threshold for mechanically induced hind paw withdrawal in rats [8, 12, 16].
Limited information is available about contribution of the vagus nerve to 
visceral pain. Chen et al. [27] reported that vagotomy enhanced visceral pain 
responses in rats. Furuta and coworkers [28] have shown that subdiaphragmatic 
vagal dysfunction caused chronic muscle hyperalgesia accompanied by visceral 
pain. The results of these experiments are contradictory to our results. 
In our experiments, animals that had undergone subdiaphragmatic vagotomy 
7 days prior to the “writhing test” showed decreased nociceptive responses to 
the infl ammatory visceral stimulus. Data obtained in our studies show that 
vagus nerve plays the direct role in conveying the nociceptive information in the 
peritonitis model of visceral pain. Several studies reported similar conclusions. 
Noxious gastric distention resulted in c-Fos expression in the nucleus of the 
solitary tract which is even more pronounced than that in the spinal cord [30]. 
This c-Fos expression could be largely ascribed to activation of vagal afferents 
and to a minor extent activation of a spino-solitary pathway. Esophageal 
distension has been shown to elicit cardiovascular refl ex responses mediated 
by vagal afferents and this has been interpreted as a nociceptive event [1]. 
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Finally, and most relevant to the overall theme of immunosensation, Watkins 
et al. [4] have demonstrated that LPS- and IL-1β-induced hyperalgesia depends 
on the integrity of the vagus nerve, particularly its common hepatic branch.
We have tested two different stimulation parameters of chronic subdia-
phragmatic vagal nerve stimulation (high intensity — VNS1 and low intensity 
— VNS2) in experimental visceral pain model in rats. Both stimulation pa-
rameters increased pain threshold in visceral pain. However VNS1 was more 
effective than VNS2. Our fi ndings are in accordance with previous studies of 
the effects of VNS. 
Bohotin et al. [14] tested the analgesic effect of two different stimulation 
protocols, one with a stringent duty cycle and one with the duty cycle used in 
epilepsy. VNS reduced signifi cantly formalin-evoked nociceptive behaviour in 
rats [14, 31]. The VNS protocol with the most stringent duty cycle, produced the 
most rapid and pronounced aninociceptive effect. However, the less stringent 
duty cycle was also able to induce antinociception, but only after days of 
stimulation. Antinociceptive effect starts after 24 h of stimulation and increases 
over the next 2 days to reach plateau. Several studies have demonstrated that 
vagus nerve stimulation (VNS) alters pain perception. A recent study showing 
changes in pain perception as a function of different VNS settings hints at 
the promise of using VNS for some form of pain modulation. Findings suggest 
that, in general, low-intensity VNS is associated with pronociceptive effects, 
but high-intensity VNS is associated with antinociceptive effects [13]. Moreover, 
acutely, VNS increases pain perception [20], but used chronically VNS results 
in a decrease in pain perception in humans [21].
Our results suggest, that VNS can infl uence the pain threshold via the 
modulation of the opioid system. Naloxone — a nonselective opiod receptors 
antagonist — inhibited the antinociceptive effects of VNS, reversing partially 
increase in the pain threshold and increases number of writhes in visceral 
pain model. Therefore, our data indicate that this analgesic effect of the VNS is 
mediated, at least in part, by descending opioidergic pathways.
The exact mechanisms by which VNS may reduce pain remain to be 
determined. The central projections of the vagus nerve suggest that the upper 
cervical spinal cord could be involved [32]. The observation that vagal stimulation 
inhibits spinal cord neurons in segments below C3 but excites C1-C3 neurons 
lead to the hypothesis that propriospinal neurons from high cervical segments 
could be an important component of vagally mediated antinociception in distant 
spinal segments [33]. Direct projections of primary vagal afferents to the upper 
cervical spinal cord have been demonstrated also in tracing studies [1]. 
Central terminals of primary vagal afferents are largely found in the 
nucleus of the solitary tract [1] which may be the initial relay for vagal afferent 
inhibition of pain [13]. Experiments using local anesthesic blockade of nucleus 
tractus solitarius but also raphe magnus, locus ceruleus and periaqueductal 
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gray suggests that these structures mediate part of the antinociceptive effects 
of VNS [34, 35]. Stimulation of vagal afferent fi bers has been reported to affect 
the basal activity of raphe magnus neurons [36]. Different neurotransmitter 
systems have been implicated in VNS-induced analgesia, in particular serotonin 
[37], noradrenaline [38] and opioids [38, 39]. GABA was found increased in the 
cerebrospinal fl uid of epileptic patients treated with VNS [40]. Vagal afferent 
impulses could also modulate pain perception via an indirect activation of the 
paraventricular nucleus, which in turn modifi es adrenaline release from the 
adrenal medulla [17]. Finally, VNS is able to increase plasma levels of ACTH 
and corticosterone [41] which could mediate some of its antinociceptive and 
anti-infl ammatory effects. 
The exact pathways of antinociceptive action of vagal afferents remain unclear. 
Therefore further investigations are needed to establish the exact mechanisms 
of vagal nerve stimulation in a different forms of pain and subsequently to 
compile the brand new antinociceptive therapeutical strategies. 
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